Importance Placebo is the only substance systematically evaluated across common
psychiatric diagnoses, but comprehensive cross-diagnostic comparisons are lacking …

Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Background. The clinician-administered version of the Liebowitz Social Anxiety Scale (LSAS-
CA) is a commonly used assessment device for the evaluation of social anxiety disorder and …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Sixty patients meeting Diagnostic and Statistical Manual of Mental Disorders (4th ed.:
American Psychiatric Association, 1994) criteria for generalized social phobia were …

Abstract The Sheehan Disability Scale (SDS) is a patient-rated, discretized analog measure
of functional disability in work, social, and family life. Its increasing use in clinical trials in …

Despite the demonstrated efficacy of cognitive-behavior therapy (CBT) for social anxiety
disorder (SAD), many individuals do not respond to treatment or demonstrate residual …

Background Generalized social phobia is common, persistent, and disabling and is often
treated with selective serotonin reuptake inhibitor drugs or cognitive behavioral therapy …

This paper reviews the current status of research on the phenomenology, etiology,
maintenance, assessment, and treatment of childhood and adolescent social anxiety …

Chronically administered antidepressant drugs, particularly selective serotonin (5-HT)
reuptake inhibitors (SSRIs), are clinically effective in the treatment of all anxiety disorders …